U.S. Multiple Sclerosis Therapies Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed. There is a competitive and product analysis of the major market participants and Market Engineering Awards are presented in various categories.

Table of Contents

U.S. Multiple Sclerosis Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Multiple Sclerosis Therapies Markets, Disease OverviewDisease OverviewOverviewPrevalence and IncidenceClinical PresentationPatient DemographicsDisease Sub-typesDiagnosisProduct AnalysisGoals of TreatmentAvonexBetaseronCopaxoneRebifDemand AnalysisBenign Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisMonosymptomatic Multiple SclerosisU.S. Multiple Sclerosis Therapies Markets, Market OverviewMarket DynamicsMarket Engineering AnalysisMedium To High Impact Market DriversLow To Medium Impact Market DriversMarket ChallengesMarket RestraintsCompetitive OverviewMarket ParticipantsProducts In DevelopmentResearch and DevelopmentProducts in Development: Phase IIIProducts in Development: Phase IIMarket Engineering AwardsProduct Differentiation Innovation - Teva NeuroSciencesProduct Launch Strategy - SeronoMarketing Strategy Leadership - Biogen Inc.Product Line Strategy - BerlexTechnology Innovation - Acorda TherapeuticsU.S. Multiple Sclerosis Therapies Markets, Revenue Forecasts and Strategic RecommendationsRevenue ForecastsRevenue Forecast Methodology and AssumptionsRevenue ForecastsStrategic RecommendationsStrategic Recommendation 1Strategic Recommendation 2Strategic Recommendation 3




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.